Publication

Article

BioPharm International

BioPharm International-12-16-2013
Volume2013 eBook
Issue 1

Crowdfunding Biopharmaceutical Innovation

Author(s):

Cameron Field

Caution should be taken when planning to crowdfund a biopharmaceutical startup.

 

Caution should be taken when planning to crowdfund a biopharmaceutical startup.
 

Read this article

from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

 

 

 

 

 

Articles in this issue
BPsupp1213_AmbrexProfile_200.jpg
Creating Better Medicines through Better Conjugation
BPsupp1213_Patent_200.jpg
Recovering Patent Life with Patent Term Extension
BPsupp1213_Vetter_200.jpg
Strategic Outsourcing in Clinical Development
BPsupp1213_NPSPharma_200.jpg
Leveraging Development Strengths Drives Therapies to Market
BPsupp1213_Kalypso_200.jpg
Driving Innovation in Biopharmaceuticals
BPsupp1213_Crowdfunding_200.jpg
Crowdfunding Biopharmaceutical Innovation

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 23rd 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 23rd 2025

Strand’s Programmable mRNA Pipeline Advances on $153 Million in New Funding

Feliza Mirasol
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 23rd 2025

Next for Biopharma: Speed, Strategy, and Smarter Systems

Mike Hennessy Jr.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 23rd 2025

European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Feliza Mirasol
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
August 23rd 2025

Polpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 23rd 2025

Lilly’s AD Therapy, Kisunla, Shows Increasing Benefit in Treatment of Early AD

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.